Caddisfly Allergy: A Rare but Real Aquatic Insect Allergen

Caddisflies (order Trichoptera) and mayflies (order Ephemeroptera) are both aquatic insects that emerge in seasonal swarms near freshwater, and both can cause IgE-mediated inhalant allergy through their shed scales and body fragments. The allergens are similar but not identical: both contain tropomyosins and arginine kinases, but the specific protein sequences differ. Clinically, the two allergies are often grouped together under 'aquatic insect allergy,' and patients sensitized to one may show cross-reactivity to the other. The primary difference is geographic and seasonal: mayfly hatches tend to be more intense but shorter-lived (a few weeks), while caddisfly hatches can extend over several months. An allergist can test for both to determine which is driving symptoms.

Anaphylaxis from inhalant caddisfly exposure alone is extremely rare. The primary risk of anaphylaxis in caddisfly-allergic patients comes from the cross-reactive crustacean food allergy: if a patient with caddisfly sensitization eats shrimp, crab, or lobster, the shared tropomyosin proteins can trigger a systemic reaction including urticaria, angioedema, and potentially anaphylaxis. Patients with confirmed caddisfly allergy who have never eaten crustaceans should discuss the risk with their allergist before doing so. Any patient who experiences throat swelling, difficulty breathing, or facial swelling after insect exposure or crustacean ingestion should seek emergency care immediately.

Yes, skin prick testing with caddisfly extract is available at some academic allergy centers and specialized clinics, particularly in the Great Lakes region and Pacific Northwest where the allergy is most prevalent. However, commercial caddisfly extract is not as widely standardized or available as extracts for more common aeroallergens like ragweed or dust mite. Patients in caddisfly-endemic areas may need to seek out an allergist at a university medical center to access this testing. Specific IgE blood testing (ImmunoCAP) for caddisfly is also available through some reference laboratories.

Caddisfly season typically runs from May through October in most of the United States, with peak activity in June, July, and August. The exact timing varies by species and latitude: in the Great Lakes region, the first major hatches begin in May and continue through September, while in the Pacific Northwest, the season may extend into October. Caddisflies are most active during evening and early morning hours. The season is predictable and finite, which allows patients to plan their medication and avoidance strategies accordingly.

Yes, caddisfly allergy is a documented trigger for asthma exacerbations in sensitized individuals. Studies of aquatic insect allergy in the Great Lakes region have found that up to 30% of sensitized patients report asthma symptoms during peak caddisfly season. The mechanism is the same as for other inhalant allergens: inhaled caddisfly particles trigger IgE-mediated inflammation in the lower airways, leading to bronchoconstriction, mucus production, and airway hyperresponsiveness. Patients with pre-existing asthma who live near freshwater should be particularly vigilant during the May–October season.

The highest-risk individuals are those who live, work, or recreate near freshwater bodies — lakes, rivers, and streams — during the May–October caddisfly emergence season. Fly-fishing guides, aquatic biologists, and fisheries workers face the highest occupational exposure. Anglers and lakeside residents are also at elevated risk. Patients with pre-existing crustacean allergy (shrimp, crab, lobster) may have cross-reactive IgE to caddisfly tropomyosins, increasing the risk of inhalant sensitization. A personal or family history of atopic disease (eczema, food allergy, other inhalant allergies) also increases the probability of developing caddisfly allergy.

Yes, new-onset respiratory allergies can develop at any age, and caddisfly allergy is no exception. Adults who move to a lakeside or riverside home and experience their first seasonal respiratory symptoms during the May–October period may be developing new caddisfly sensitization driven by exposure they did not have previously. The mechanism is the same regardless of age: repeated exposure to caddisfly particles in a genetically susceptible individual can eventually drive IgE sensitization and symptomatic rhinoconjunctivitis. This clinical presentation — 'I never had allergies before I moved to the lake' — should prompt evaluation with an allergist familiar with aquatic insect allergy.

Not exactly, but they are related. Caddisfly allergy is an inhalant allergy to proteins from aquatic insects, while shellfish allergy is a food allergy to crustaceans (shrimp, crab, lobster) or mollusks (clams, mussels, oysters). The connection is tropomyosin: both caddisflies and crustaceans contain tropomyosin proteins with highly similar structures. This means that a patient sensitized to caddisfly tropomyosin may have cross-reactive IgE that also recognizes crustacean tropomyosin, potentially causing allergic reactions when eating shrimp, crab, or lobster. However, not all patients with caddisfly allergy develop clinical crustacean allergy, and vice versa. An allergist can clarify the relationship through specific IgE testing.

You can still fish, but planning is essential. Fish during midday hours when caddisfly activity is lowest, rather than during evening or early morning hatches. Wear long sleeves, pants, and an N95 mask to reduce inhalation and skin contact with caddisfly particles. Pre-treat with an antihistamine 1–2 hours before heading out. Keep a rescue inhaler (if you have asthma) and an epinephrine auto-injector (if you have crustacean cross-reactivity) accessible. Shower and change clothes immediately after returning home. If symptoms are severe despite these measures, discuss allergen immunotherapy with your allergist.

Yes, allergen immunotherapy with caddisfly extract — delivered as either subcutaneous injections (allergy shots) or sublingual drops — is a well-established treatment in the limited geographic regions where the allergy is prevalent. Published case series from specialized centers in the Great Lakes region and Pacific Northwest demonstrate 60–80% symptom reduction in patients who complete a 3–5 year course. The extract is not commercially available from standard manufacturers but can be compounded at specialized pharmacies. Patients interested in this option should seek out an allergist at an academic medical center with experience in aquatic insect allergy.